;wherein R1, R2, R3, R4, W, X, and Y are as defined hereinbefore or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia."/>
公开/公告号US6743787B2
专利类型
公开/公告日2004-06-01
原文格式PDF
申请/专利权人 WYETH;
申请/专利号US20020205019
申请日2002-07-25
分类号C07D4011/20;C07D2115/80;C07D4010/40;C07D4171/40;A61K314/545;
国家 US
入库时间 2022-08-21 23:15:40